Currently predicting for Mon, 1 Apr 2024

Trading levels for IMUC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.307 101.75 %
R2 0.262 72.60 %
R1 0.235 54.59 %
Current price: 0.152
Support S1 0.146 -3.71 %
S2 0.119 -21.72 %
S3 0.0747 -50.88 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0.183 20.39 %
Current price 0.152
Support S1 0 .
S2 0 .
S3 0 .

IMUC Predictions History

3 years ago
JS predicted that IMUC for 2020-12-07 is going $0.307 (6.23%)

4 years ago
NameNotImportant predicted that IMUC for 2019-05-06 is going $0.0220 (-8.33%)

5 years ago
JS predicted that IMUC for 2019-02-07 is going $0.0280 (-3.45%)

5 years ago
PumpTheseNumbers predicted that IMUC for 2019-02-07 is going $0.0280 (-3.45%)

5 years ago
JS predicted that IMUC for 2019-02-04 is going $0.0260 (-10.65%)

5 years ago
JS predicted that IMUC for 2019-01-30 is going $0.0300 (7.14%)

5 years ago
JS predicted that IMUC for 2019-01-29 is going $0.0310 (-3.13%)

5 years ago
JS predicted that IMUC for 2019-01-24 is going $0.0290 (3.57%)

5 years ago
Jeff.Kinney.97458 predicted that IMUC for 2019-01-24 is going $0.0210 (-25.00%)

Rank:

5 years ago
Joey.floyd.96225 predicted that IMUC for 2019-01-24 is going $0.0200 (-29.82%)

Rank:
Click to get the best stock tips daily for free!

About ImmunoCellular Therapeutics Ltd

ImmunoCellular Therapeutics  Ltd Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev... IMUC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT